Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43

Connexin43 (Cx43) is involved in bone development, but its role in adult bone homeostasis remains unknown. To overcome the postnatal lethality of Cx43 null mutation, we generated mice with selective osteoblast ablation of Cx43, obtained using a Cx43fl allele and a 2.3-kb fragment of the α1(I) collagen promoter to drive Cre in osteoblasts (ColCre). Conditionally osteoblast-deleted ColCre;Cx43–/fl mice show no malformations at birth, but develop low peak bone mass and remain osteopenic with age, exhibiting reduced bone formation and defective osteoblast function. By both radiodensitometry and histology, bone mineral content increased rapidly and progressively in adult Cx43+/fl mice after subcutaneous injection of parathyroid hormone (PTH), an effect significantly attenuated in ColCre;Cx43–/fl mice, with Cx43–/fl exhibiting an intermediate response. Attenuation of PTH anabolic action was associated with failure to increase mineral apposition rate in response to PTH in ColCre;Cx43–/fl, despite an increased osteoblast number, suggesting a functional defect in Cx43-deficient bone-forming cells. In conclusion, lack of Cx43 in osteoblasts leads to suboptimal acquisition of peak bone mass, and hinders the bone anabolic effect of PTH. Cx43 represents a potential target for modulation of bone anabolism.

[1]  Colin McKerlie,et al.  A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia , 2005, Development.

[2]  L. Bonewald,et al.  Mechanical strain opens connexin 43 hemichannels in osteocytes: a novel mechanism for the release of prostaglandin. , 2005, Molecular biology of the cell.

[3]  J. Wysolmerski,et al.  TOPGAL Mice Show That the Canonical Wnt Signaling Pathway Is Active During Bone Development and Growth and Is Activated by Mechanical Loading In Vitro , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  E. Jabs,et al.  Functional Characterization of Connexin43 Mutations Found in Patients With Oculodentodigital Dysplasia , 2005, Circulation research.

[5]  M. Bouxsein,et al.  The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone. , 2005, Endocrinology.

[6]  D. Laird,et al.  Oculodentodigital Dysplasia-causing Connexin43 Mutants Are Non-functional and Exhibit Dominant Effects on Wild-type Connexin43* , 2005, Journal of Biological Chemistry.

[7]  J. Stains,et al.  Cell-cell interactions in regulating osteogenesis and osteoblast function. , 2005, Birth defects research. Part C, Embryo today : reviews.

[8]  S. Manolagas,et al.  Bisphosphonates and Estrogens Inhibit Osteocyte Apoptosis via Distinct Molecular Mechanisms Downstream of Extracellular Signal-regulated Kinase Activation* , 2005, Journal of Biological Chemistry.

[9]  Su‐Li Cheng,et al.  β‐Catenin and BMP‐2 synergize to promote osteoblast differentiation and new bone formation , 2005, Journal of cellular biochemistry.

[10]  B. de Crombrugghe,et al.  Transgenic mice expressing a ligand-inducible cre recombinase in osteoblasts and odontoblasts: a new tool to examine physiology and disease of postnatal bone and tooth. , 2004, The American journal of pathology.

[11]  J. Stains,et al.  Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. , 2004, Molecular biology of the cell.

[12]  Toshitaka Nakamura,et al.  Skeletal Unloading Alleviates the Anabolic Action of Intermittent PTH(1–34) in Mouse Tibia in Association With Inhibition of PTH‐Induced Increase in c‐fos mRNA in Bone Marrow Cells , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Su‐Li Cheng,et al.  Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis , 2004, Journal of Cell Science.

[14]  J. Opitz,et al.  Novel Connexin 43 (GJA1) mutation causes oculo–dento–digital dysplasia with curly hair , 2004, American journal of medical genetics. Part A.

[15]  B. Giepmans.  Gap junctions and connexin-interacting proteins. , 2004, Cardiovascular research.

[16]  F. Meire,et al.  Expression of Gja1 correlates with the phenotype observed in oculodentodigital syndrome/type III syndactyly , 2004, Journal of Medical Genetics.

[17]  M. C. Brañes,et al.  Plasma membrane channels formed by connexins: their regulation and functions. , 2003, Physiological reviews.

[18]  F. Lecanda,et al.  Gap Junctional Communication Modulates Gene Transcription by Altering the Recruitment of Sp1 and Sp3 to Connexin-response Elements in Osteoblast Promoters* , 2003, Journal of Biological Chemistry.

[19]  Bernd Wollnik,et al.  Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. , 2003, American journal of human genetics.

[20]  U. Heinemann,et al.  Accelerated Hippocampal Spreading Depression and Enhanced Locomotory Activity in Mice with Astrocyte-Directed Inactivation of Connexin43 , 2003, The Journal of Neuroscience.

[21]  K. Willecke,et al.  Development of Mice with Osteoblast-Specific Connexin43 Gene Deletion , 2003, Cell communication & adhesion.

[22]  G. Karsenty,et al.  Mouse α1(I)‐collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[23]  T. Loddenkemper,et al.  Neurological manifestations of the oculodentodigital dysplasia syndrome , 2002, Journal of Neurology.

[24]  R. Lindsay,et al.  Anabolic Action of Parathyroid Hormone Is Skeletal Site Specific at the Tissue and Cellular Levels in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  C. Jacobs,et al.  Gap junctions and fluid flow response in MC3T3-E1 cells. , 2001, American journal of physiology. Cell physiology.

[26]  J. Reginster,et al.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. , 2001, The New England journal of medicine.

[27]  P. Schiller,et al.  Inhibition of Gap-Junctional Communication Induces the Trans-differentiation of Osteoblasts to an Adipocytic Phenotype in Vitro * , 2001, The Journal of Biological Chemistry.

[28]  P. Schiller,et al.  Gap-junctional communication is required for the maturation process of osteoblastic cells in culture. , 2001, Bone.

[29]  R. Baron,et al.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. , 2001, The Journal of clinical investigation.

[30]  L. Bonewald,et al.  Expression of Functional Gap Junctions and Regulation by Fluid Flow in Osteocyte‐Like MLO‐Y4 Cells , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  K. Willecke,et al.  Endothelium‐specific replacement of the connexin43 coding region by a lacZ reporter gene , 2001, Genesis.

[32]  T. Steinberg,et al.  Connexin43 Deficiency Causes Delayed Ossification, Craniofacial Abnormalities, and Osteoblast Dysfunction , 2000, The Journal of cell biology.

[33]  F. Lecanda,et al.  Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways , 2000, Journal of cellular biochemistry.

[34]  T. Steinberg,et al.  Human Osteoblastic Cells Propagate Intercellular Calcium Signals by Two Different Mechanisms , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  Andras Nagy,et al.  Cre recombinase: The universal reagent for genome tailoring , 2000, Genesis.

[36]  H J Donahue,et al.  Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. , 2000, American journal of physiology. Cell physiology.

[37]  P. Roberson,et al.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. , 1999, The Journal of clinical investigation.

[38]  P. Kostenuik,et al.  Skeletal Unloading Causes Resistance of Osteoprogenitor Cells to Parathyroid Hormone and to Insulin‐like Growth Factor‐I , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  G. Karsenty,et al.  Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in Vivo * , 1998, The Journal of Biological Chemistry.

[40]  T. Steinberg,et al.  Gap junctional communication modulates gene expression in osteoblastic cells. , 1998, Molecular biology of the cell.

[41]  C. Rubin,et al.  Gap Junctional Intercellular Communication Contributes to Hormonal Responsiveness in Osteoblastic Networks (*) , 1996, The Journal of Biological Chemistry.

[42]  T. Steinberg,et al.  Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43 , 1995, The Journal of cell biology.

[43]  R. Turner,et al.  Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. , 1995, Endocrinology.

[44]  H J Donahue,et al.  Cell‐to‐cell communication in osteoblastic networks: Cell line–dependent hormonal regulation of gap junction function , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  B L Langille,et al.  Cardiac malformation in neonatal mice lacking connexin43. , 1995, Science.

[46]  P. Brink,et al.  Selective dye and ionic permeability of gap junction channels formed by connexin45. , 1994, Circulation research.

[47]  T. Steinberg,et al.  Connexin43 and connexin45 form gap junctions with different molecular permeabilities in osteoblastic cells. , 1994, The EMBO journal.

[48]  T. Steinberg,et al.  Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. , 1993, The Journal of clinical investigation.

[49]  A. Fujimori,et al.  Heterogeneous intracellular free calcium responses to parathyroid hormone correlate with morphology and receptor distribution in osteogenic sarcoma cells. , 1992, Endocrinology.

[50]  D. Kalu,et al.  Human parathyroid hormone‐(1‐34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  M J McLeod,et al.  Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. , 1980, Teratology.

[53]  M. Drezner,et al.  Annual Meeting of the American Society for Bone and Mineral Research , 2003 .

[54]  H. Thomas,et al.  Transfected Connexin 45 Alters Gap Junction Permeability in Cells Expressing Endogenous Connexin 43 , 2002 .

[55]  P. Schiller,et al.  Gap-junctional communication mediates parathyroid hormone stimulation of mineralization in osteoblastic cultures. , 2001, Bone.

[56]  C. Naus,et al.  Doubly mutant mice, deficient in connexin32 and -43, show normal prenatal development of organs where the two gap junction proteins are expressed in the same cells. , 1999, Developmental genetics.

[57]  T. Steinberg,et al.  Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. , 1998, Journal of cellular biochemistry.

[58]  T. Steinberg,et al.  Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells , 1998 .

[59]  J. Fryns,et al.  Type III syndactyly and oculodentodigital dysplasia: a clinical spectrum. , 1993, Genetic counseling.

[60]  P. Demoly,et al.  [Transgenic mice]. , 1992, Annales de dermatologie et de venereologie.

[61]  J M Hock,et al.  Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. , 1984, Metabolic bone disease & related research.